ANXA2 and osteosarcoma: ANXA2 knockdown re-activated autophagy and attenuated CDDP resistance in osteosarcoma19.Therefore, ANXA2 appears to be a key molecule in studying the biological behavior of tumors and may represent a potential target for future therapeutic interventions, warranting further exploration of its mechanisms within osteosarcoma.